Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Roche Holding AG RHHVF OTC

Other OTC • Healthcare • Drug Manufacturers - General • CH • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Roche Holding AG (RHHVF) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 3 Buy, 5 Hold, 1 Sell.

RHHVF Analyst Ratings

Hold
9
Ratings
3 Buy
5 Hold
1 Sell
Based on 9 analysts giving stock ratings to Roche Holding AG in the past 3 months
Rating breakdown
Buy
3 33%
Hold
5 56%
Sell
1 11%
33%
Buy
3 analysts
56%
Hold
5 analysts
11%
Sell
1 analysts

People Also View

RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AZNCF
AZNCF
AstraZeneca PLC
$189.90
-1.35%
 GSK
GSK
GSK plc
$59.18
+0.41%
 BMY
BMY
Bristol-Myers Squibb Company
$58.08
+0.03%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message